FDA Quietly Admits to Creating Martin Shkreli

Published April 13, 2016 7:00pm ET



There’s a “demotivational” poster that reads, “Mistakes: It could be that the purpose of your life is only to serve as a warning to others.”

That seems to be the takeaway for the FDA, which just quietly changed its rules to approve certain drugs faster. The agency made this change (so they claim) to combat companies like Turing Pharmaceuticals, which became a public enemy number one overnight when it hiked the price of one drug from $13.50 per pill to $750. Turing’s then-CEO Martin Shkreli was called “evil“, “opportunistic“, and “capitalist” when he raised the price of Daraprim, which is often prescribed to HIV/AIDS patients, pregnant women, and babies.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.